SEC Form SC 13G/A filed by XOMA Corporation (Amendment)

2/9/23 12:46:50 PM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Get the next $XOMA alert in real time by email

SC 13G/A 1 filing.txt SCHEDULE 13G Amendment No.2 XOMA CORP COMMON STOCK Cusip #98419J206 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) Cusip #98419J206 Item 1: Reporting Person - FMR LLC Item 2: (a) [ ] (b) [ ] Item 4: Delaware Item 5: 1,246,579 Item 6: 0 Item 7: 1,246,686 Item 8: 0 Item 9: 1,246,686 Item 11: 10.887% Item 12: HC Cusip #98419J206 Item 1: Reporting Person - Abigail P. Johnson Item 2: (a) [ ] (b) [ ] Item 4: United States of America Item 5: 0 Item 6: 0 Item 7: 1,246,686 Item 8: 0 Item 9: 1,246,686 Item 11: 10.887% Item 12: IN Item 1(a). Name of Issuer: XOMA CORP Item 1(b). Address of Issuer's Principal Executive Offices: 2200 POWELL STREET, SUITE 310 EMERYVILLE, CA 94608 USA Item 2(a). Name of Person Filing: FMR LLC Item 2(b). Address or Principal Business Office or, if None, Residence: 245 Summer Street, Boston, Massachusetts 02210 Item 2(c). Citizenship: Not applicable Item 2(d). Title of Class of Securities: COMMON STOCK Item 2(e). CUSIP Number: 98419J206 Item 3. This statement is filed pursuant to Rule 13d-1(b) or 13d-2(b) or (c) and the person filing, FMR LLC, is a parent holding company in accordance with Section 240.13d-1(b)(1)(ii)(G). (Note: See Exhibit A). Item 4. Ownership (a) Amount Beneficially Owned: 1,246,686 (b) Percent of Class: 10.887% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: Please see the responses to Items 5 and 6 on the cover page (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 1,246,686 (iv) shared power to dispose or to direct the disposition of: 0 Item 5. Ownership of Five Percent or Less of a Class. Not applicable. Item 6. Ownership of More than Five Percent on Behalf of Another Person. One or more other persons are known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the COMMON STOCK of XOMA CORP. No one other person's interest in the COMMON STOCK of XOMA CORP is more than five percent of the total outstanding COMMON STOCK. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. See attached Exhibit A. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing orinfluencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. February 9, 2023 Date /s/ Stephanie J. Brown Signature Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. Exhibit A Pursuant to the instructions in Item 7 of Schedule 13G, the following table lists the identity and Item 3 classification, if applicable, of each relevant entity that beneficially owns shares of the security class being reported on this Schedule 13G. Entity ITEM 3 Classification Fidelity Management & Research Company LLC * IA Strategic Advisers LLC IA * Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Abigail P. Johnson is a Director, the Chairman and the Chief Executive Officer of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. This filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by FMR LLC, certain of its subsidiaries and affiliates, and other companies (collectively, the "FMR Reporters"). This filing does not reflect securities, if any, beneficially owned by certain other companies whose beneficial ownership of securities is disaggregated from that of the FMR Reporters in accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998). RULE 13d-1(k)(1) AGREEMENT The undersigned persons, on February 9, 2023, agree and consent to the joint filing on their behalf of this Schedule 13G in connection with their beneficial ownership of the COMMON STOCK of XOMA CORP at December 30, 2022. FMR LLC By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January 3, 2023, by and on behalf of FMR LLC and its direct and indirect subsidiaries* Abigail P. Johnson By /s/ Stephanie J. Brown Stephanie J. Brown Duly authorized under Power of Attorney effective as of January, 26, 2023, by and on behalf of Abigail P. Johnson** * This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 10, 2023, accession number: 0000315066-23-000003. ** This power of attorney is incorporated herein by reference to Exhibit 24 to the Schedule 13G filed by FMR LLC on January 31, 2023, accession number: 0000315066-23-000038.

Get the next $XOMA alert in real time by email

Recent Analyst Ratings for

$XOMA

Date	Price Target	Rating	Analyst
4/17/2025	$35.00	Buy	The Benchmark Company
4/29/2024	$40.00	Outperform	Leerink Partners
10/8/2021	$56.00 → $69.00	Buy	HC Wainwright & Co.
9/9/2021	$60.00 → $56.00	Buy	Aegis Capital
9/7/2021	$22.00	Outperform → Neutral	Wedbush
9/7/2021	$22.00	Neutral → Underperform	Wedbush
6/29/2021	$60.00	Buy	Aegis Capital

More analyst ratings

SEC Form SC 13G/A filed by XOMA Corporation (Amendment)

Chat with this insight

Recent Analyst Ratings for $XOMA

$XOMA Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

The Benchmark Company initiated coverage on XOMA Royalty Corporation with a new price target

Leerink Partners initiated coverage on XOMA with a new price target

HC Wainwright & Co. reiterated coverage on XOMA with a new price target

$XOMA Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Chief Investment Officer Sitko Bradley bought $49,400 worth of Depositary Shares - 8.375% Series B Cumulative Stock (2,000 units at $24.70), increasing direct ownership by 66% to 5,045 units (SEC Form 4)

Director Limber Joseph M bought $504,504 worth of Depositary Shares - 8.375% Series B Cumulative Stock (20,000 units at $25.23) and bought $255,640 worth of 8.625% Series A Cumulative Perpetual Preferred Stock (10,000 units at $25.56) (SEC Form 4)

Chief Investment Officer Sitko Bradley bought $19,980 worth of shares (1,000 units at $19.98) and bought $6,221 worth of Depositary Shares - 8.375% Series B Perpetual Preferred (245 units at $25.39), decreasing direct ownership by 71% to 3,045 units (SEC Form 4)

$XOMA Financials

Live finance-specific insights

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

XOMA Royalty Declares Quarterly Preferred Stock Dividends

XOMA Royalty Declares Quarterly Preferred Stock Dividends

$XOMA Press Releases

Fastest customizable press release news feed in the world

XOMA Royalty to Present at H.C. Wainwright 1st Annual Royalty Company Virtual Conference

XOMA Royalty Completes Sale of Kinnate Pipeline Assets

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

$XOMA Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

Chief Investment Officer Sitko Bradley bought $49,400 worth of Depositary Shares - 8.375% Series B Cumulative Stock (2,000 units at $24.70), increasing direct ownership by 66% to 5,045 units (SEC Form 4)

Director Limber Joseph M bought $504,504 worth of Depositary Shares - 8.375% Series B Cumulative Stock (20,000 units at $25.23) and bought $255,640 worth of 8.625% Series A Cumulative Perpetual Preferred Stock (10,000 units at $25.56) (SEC Form 4)

Chief Investment Officer Sitko Bradley bought $19,980 worth of shares (1,000 units at $19.98) and bought $6,221 worth of Depositary Shares - 8.375% Series B Perpetual Preferred (245 units at $25.39), decreasing direct ownership by 71% to 3,045 units (SEC Form 4)

$XOMA Large Ownership Changes

This live feed shows all institutional transactions in real time.

SEC Form SC 13G/A filed by XOMA Corporation (Amendment)

SEC Form SC 13D/A filed by XOMA Corporation (Amendment)

SEC Form SC 13G/A filed by XOMA Corporation (Amendment)

$XOMA Leadership Updates

Live Leadership Updates

XOMA Reports First Quarter 2024 Financial Results and Highlights Recent Activities

Actym Therapeutics Appoints Thomas Smart as CEO

XOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directors

$XOMA SEC Filings

SEC Form DEF 14A filed by XOMA Royalty Corporation

SEC Form PRE 14A filed by XOMA Royalty Corporation

SEC Form 10-K filed by XOMA Royalty Corporation

Recent Analyst Ratings for
$XOMA

$XOMA
Analyst Ratings

$XOMA
Insider Purchases

$XOMA
Financials

$XOMA
Press Releases

$XOMA
Insider Trading

$XOMA
Large Ownership Changes

$XOMA
Leadership Updates

$XOMA
SEC Filings